000739 Stock Overview
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Apeloa Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.31 |
| 52 Week High | CN¥18.96 |
| 52 Week Low | CN¥12.23 |
| Beta | 0.14 |
| 1 Month Change | 0.79% |
| 3 Month Change | -3.95% |
| 1 Year Change | 12.91% |
| 3 Year Change | -54.82% |
| 5 Year Change | -16.16% |
| Change since IPO | 834.58% |
Recent News & Updates
Apeloa PharmaceuticalLtd's (SZSE:000739) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 17
Earnings Miss: Apeloa Pharmaceutical Co.,Ltd Missed EPS By 9.7% And Analysts Are Revising Their Forecasts
Mar 13Recent updates
Apeloa PharmaceuticalLtd's (SZSE:000739) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 17Earnings Miss: Apeloa Pharmaceutical Co.,Ltd Missed EPS By 9.7% And Analysts Are Revising Their Forecasts
Mar 13Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E No Reason For Excitement
Feb 11We Think Apeloa PharmaceuticalLtd (SZSE:000739) Can Stay On Top Of Its Debt
Jan 13Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough
Nov 09Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly
Sep 30Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E
Aug 07Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?
Jun 24Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
May 08Shareholder Returns
| 000739 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.5% | 1.7% | 1.6% |
| 1Y | 12.9% | -2.2% | 12.5% |
Return vs Industry: 000739 exceeded the CN Pharmaceuticals industry which returned -2.2% over the past year.
Return vs Market: 000739 matched the CN Market which returned 12.5% over the past year.
Price Volatility
| 000739 volatility | |
|---|---|
| 000739 Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 3.4% |
Stable Share Price: 000739 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000739's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 7,060 | Chun He | www.apeloa.com |
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.
Apeloa Pharmaceutical Co.,Ltd Fundamentals Summary
| 000739 fundamental statistics | |
|---|---|
| Market cap | CN¥17.74b |
| Earnings (TTM) | CN¥1.03b |
| Revenue (TTM) | CN¥12.02b |
17.2x
P/E Ratio1.5x
P/S RatioIs 000739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000739 income statement (TTM) | |
|---|---|
| Revenue | CN¥12.02b |
| Cost of Revenue | CN¥9.23b |
| Gross Profit | CN¥2.80b |
| Other Expenses | CN¥1.77b |
| Earnings | CN¥1.03b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Mar 27, 2025
| Earnings per share (EPS) | 0.89 |
| Gross Margin | 23.26% |
| Net Profit Margin | 8.58% |
| Debt/Equity Ratio | 13.2% |
How did 000739 perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield40%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/18 03:42 |
| End of Day Share Price | 2025/03/18 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apeloa Pharmaceutical Co.,Ltd is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wanhua Wu | China International Capital Corporation Limited |
| Kai Wang | Citic Securities Co., Ltd. |
| Siyu Peng | Guosen Securities Co., Ltd. |